Science Angel Syndicate
VC Fund
Bristol, United Kingdom
Science Angel Syndicate is a entrepreneurs and investors source world class scientific discoveries that impact society on a global scale.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Science Angel Syndicate invests in
Stages Science Angel Syndicate invests in
Countries Science Angel Syndicate invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- Medical 3 (33%)
- Biotechnology 3 (33%)
- AgTech 1 (11%)
- Chemical 1 (11%)
- Diabetes 1 (11%)
Stage
- Seed 8 (89%)
- Pre-Seed 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Johnathan Matlock
Co-Founder
|
Co-Founder | Total investments: 9 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Albotherm
|
Albotherm offers a smart transitioning coating technology that regulates the temperature of surfaces and structures without the need for energy input. When temperatures rise above a determined trigger temperature, our technology reversibly transitions from clear to white, reflecting away unwanted light to prevent overheating. | $2M / Seed / Jun 07, 2023 | |
OSSTEC
|
OSSTEC is bringing advanced technology to the operating room with metal 3D printed bone healing implants. The orthopaedic implants emulate natural bone structure and address high failure rates of existing implants, keeping patients who suffer with osteoarthritis healthy, active and enjoying life. | $1.5M / Seed / Mar 30, 2023 | |
EnsiliTech
|
EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials. | $1.1M / Pre-Seed / Jan 17, 2023 | |
QV Bioelectronics
|
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Ourco-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients. | $2.4M / Seed / Jan 10, 2023 | |
cheMastery
|
CheMastery is a company that creates laboratory automation technology. They provide automation solutions for chemical laboratories in order to facilitate the manufacturing and R&D processes in the chemical sector. It makes science more effective and reliable for scientists in the chemical sector. | Seed / Nov 13, 2022 | |
Transdermal Diagnostics
|
Transdermal Diagnostics is a technology platform to improve the prevention, diagnosis, and management of chronic conditions with diabetes. | $920.9K / Seed / Sep 06, 2022 | |
Zentraxa
|
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existingbio-design limits imposed by conventional peptide synthesis, with one universal process. | Seed / May 27, 2022 | |
MitoRx Therapeutics
|
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction. | Seed / Apr 25, 2022 | |
WASE
|
WASE provides a decentralized sanitation system with the goal of accelerating the global adoption of circular waste treatment. The company was founded in 2017 and is headquartered in London. | $923.6K / Seed / Mar 24, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Science Angel Syndicate invest in?
Science Angel Syndicate invests primarily in Medical, Biotechnology and AgTech startups, most often at Seed and Pre-Seed stage. Most of the 9 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Science Angel Syndicate?
Public channels for Science Angel Syndicate include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Science Angel Syndicate?
The team at Science Angel Syndicate includes Johnathan Matlock (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
